According to LianBio's latest financial reports the company has โน21.56 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | โน25.02 B | -12.29% |
2021-12-31 | โน28.52 B | 53.35% |
2020-12-31 | โน18.60 B | 502.43% |
2019-12-31 | โน3.08 B |